Balancing risks and benefits in the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer

被引：0
作者：
Unsworth-White, Samantha [1 ]
Humayun-Zakaria, Nada [2 ,3 ]
Bryan, Richard T. [3 ]
机构：
[1] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, England
[3] Univ Birmingham, Bladder Canc Res Ctr, Birmingham B15 2TT, England
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2025年 / 14卷 / 01期
关键词：
Atezolizumab; circulating-tumour DNA (ctDNA); non-muscle-invasive bladder cancer (NMIBC); Bacillus Calmette-Guerin-unresponsive (BCG-unresponsive); immuno-oncology; OPEN-LABEL; ATEZOLIZUMAB; MULTICENTER; BCG;
D O I：
10.21037/tau-24-529
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [41] A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guerin in Patients with High-risk Non- muscle-invasive Bladder Cancer
    Inman, Brant A.
    Hahn, Noah M.
    Stratton, Kelly
    Kopp, Ryan
    Sankin, Alex
    Skinner, Eila
    Pohar, Kamal
    Gartrell, Benjamin A.
    Pham, Song
    Rishipathak, Deepali
    Mariathasan, Sanjeev
    Davarpanah, Nicole
    Carter, Corey
    Steinberg, Gary D.
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (03): : 313 - 320
  • [42] CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer
    Steinberg, Gary D.
    Shore, Neal D.
    Redorta, Joan Palou
    Galsky, Matthew D.
    Bedke, Jens
    Ku, Ja Hyeon
    Kretkowski, Michal
    Hu, Hailong
    Penkov, Konstantin
    Vermette, Jennifer J.
    Tarazi, Jamal C.
    Randall, Alison E.
    Pierce, Kristen J.
    Saltzstein, Daniel
    Powles, Thomas B.
    FUTURE ONCOLOGY, 2024, 20 (14) : 891 - 901
  • [43] Long-term efficacy of two sequential induction courses of Bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer
    Seo, Ho Kyung
    Jung, Eui Hyun
    Song, Geehyun
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2025, 14 (01) : 4 - 7
  • [44] Gender-Specific Differences in Recurrence and Progression following Bacillus Calmette-Guerin Instillation for Non-Muscle-Invasive Bladder Cancer
    Schneidewind, Laila
    Kiss, Bernhard
    Kranz, Jennifer
    Zengerling, Friedemann
    Borkowetz, Angelika
    Graf, Sebastian
    Graser, Annabel
    Uhlig, Annemarie
    UROLOGIA INTERNATIONALIS, 2024,
  • [45] Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG Discontinuation
    Lin, Po-Ting
    Hsieh, Ming-Li
    Su, Shih-Huan
    Chang, Ying-Hsu
    Huang, Liang-Kang
    Chu, Yuan-Cheng
    Kan, Hung-Cheng
    Lin, Po-Hung
    Yu, Kai-Jie
    Chuang, Cheng-Keng
    Wu, Chun-Te
    Pang, See-Tong
    Shao, I-Hung
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3121 - 3130
  • [46] The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancer
    Liu, Kang
    Nicoletti, Rossella
    Zhao, Hongda
    Chen, Xuan
    Chiu, Peter Ka-Fung
    Ng, Chi-Fai
    Pichler, Renate
    Mertens, Laura S.
    Yanagisawa, Takafumi
    Afferi, Luca
    Mari, Andrea
    Katayama, Satoshi
    Rivas, Juan Gomez
    Campi, Riccardo
    Mir, Maria Carmen
    Rink, Michael
    Lotan, Yair
    Roupret, Morgan
    Shariat, Shahrokh F.
    Teoh, Jeremy Yuen-Chun
    BJU INTERNATIONAL, 2025, 135 (01) : 88 - 94
  • [47] Hyperthermic intravesical chemotherapy with mitomycin-C for the treatment of high-risk non-muscle-invasive bladder cancer patients
    Conroy, Samantha
    Pang, Karl
    Jubber, Ibrahim
    Hussain, Syed A.
    Rosario, Derek J.
    Cumberbatch, Marcus G.
    Catto, James W. F.
    Noon, Aidan P.
    BJUI COMPASS, 2023, 4 (03): : 314 - 321
  • [48] Experience with Newer Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer
    Barlow, LaMont J.
    Benson, Mitchell C.
    CURRENT UROLOGY REPORTS, 2013, 14 (02) : 65 - 70
  • [49] Immunotherapy of High Risk Non-Muscle Invasive Bladder Cancer
    Ahdoot, Michael
    Theodorescu, Dan
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (11) : 1345 - 1352
  • [50] Experience with Newer Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer
    LaMont J. Barlow
    Mitchell C. Benson
    Current Urology Reports, 2013, 14 : 65 - 70
12345